FDA Finalizes Device Symbol-In-Labeling Rule Retaining Glossary Requirement
This article was originally published in The Gray Sheet
Executive Summary
Industry complaints that a 2013 FDA proposal calling for a glossary explanation for standalone symbols used in device labels went beyond internationally harmonized standards did not persuade the agency to drop the glossary from its June 14 final rule, but FDA does provide more flexibility on symbols that can be employed in device labeling.
You may also be interested in...
Comments Open On Symbols In Device Labeling
US FDA is reopening the comment period on a rule that allows medical device manufacturers to use standardized symbols on product labeling. The docket will be open through May 20.
FDA’s Device Labeling Proposed Rule Misses The Mark, Industry Says
While device firms say FDA’s proposed rule on symbols in device labeling is needed, they say additional requirements for explanations of symbols in an accompanying glossary are duplicative.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.